ArticleArthritis research & therapy2025

Soquelitinib inhibition of IL-2-inducible T cell kinase ameliorates lung damage in murine models of systemic sclerosis.

Gonçalo Boleto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.